Chou R, Hartung D, Turner J et al (2020) Opioid treatments for chronic pain, in (Comparative Effectiveness Review, No. 229). In: Chou R, Hartung D, Turner J (eds) Agency for Healthcare Research and Quality, US

Osowicka M, Janowiak P, Gorzewska A et al (2022) Inhaled opioids for cancer pain relief: a narrative review. Medicine 101:e28921

Article  CAS  PubMed  PubMed Central  Google Scholar 

Licht TW, Bache NJ, Bredahl C et al (2020) Opioider til kroniske nonmaligne smerter. Ugeskr Læger 182:V08190447

PubMed  Google Scholar 

United Nations Office on Drugs and Crime.,(2021) Drug market trends: Cannabis opiods, Booklet 3 World Drug Report 2021, ed. Division for Policy Analysis and Public Affairs., Vienna Austria: The United Nations Office on Drugs and Crime

Damari B, Almadani H, Pishkuhi MA (2018) Iranian drug use survey in workplaces: a study protocol. Med J Islam Repub Iran 32:93

PubMed  PubMed Central  Google Scholar 

Mattson CL, Tanz LJ, Quinn K et al (2021) Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013–2019. Morb Mortal Wkly Rep 70:202

Article  Google Scholar 

Jones KF, Fu MR, Merlin JS et al (2021) Exploring factors associated with long-term opioid therapy in cancer survivors: an integrative review. J Pain Symptom Manage 61:395–415

Article  PubMed  Google Scholar 

Karimi G, Moshiri M, Etemad L (2009) Review of cases of lead poisoning from opium abuse in Iran. Pharmacol online 3:897–905

Google Scholar 

Banaye Yazdipour A, Moshiri M, Dadpour B et al (2022) The trend of top five types of poisonings in hospitalized patients based on ICD-10 in the northeast of Iran during 2012–2018: a cross-sectional study. Health Sci Rep 5:e587

Article  PubMed  PubMed Central  Google Scholar 

Moshiri M, Hedjazi A, Rezazadeh-Shojaie SM et al (2020) Child death due to dermal opium application: a case report. Iranian J Toxicol 14:59–62

Article  Google Scholar 

Ramazani Y, Nemati A, Moshiri M et al (2023) Gastric obstruction by opium packets: a case report. Addict Health 14:309–311

Article  Google Scholar 

Argoff CE (2020) Opioid-induced constipation: a review of health-related quality of life, patient burden, practical clinical considerations, and the impact of peripherally acting µ-opioid receptor antagonists. Clin J Pain 36:716

Article  PubMed  PubMed Central  Google Scholar 

Saini HS, Alvi Z, Singh B et al (2020) Methylnaltrexone and naloxone for opioid-induced constipation in the critical care setting. Cureus 12

Gaertner J, Siemens W, Camilleri M et al (2015) Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review. J Clin Gastroenterol 49:9–16

Article  CAS  PubMed  Google Scholar 

Kalso E, Edwards JE, Moore RA et al (2004) Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112:372–380

Article  CAS  PubMed  Google Scholar 

Lucak S, Lunsford TN, Harris LA (2021) Evaluation and treatment of constipation in the geriatric population. Clin Geriatr Med 37:85–102

Article  PubMed  Google Scholar 

Nee J, Zakari M, Sugarman MA et al (2018) Efficacy of treatments for opioid-induced constipation: systematic review and meta-analysis. Clin Gastroenterol Hepatol 16:1569–1584

Article  CAS  PubMed  Google Scholar 

Vijayvargiya P, Camilleri M, Vijayvargiya P et al (2020) Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation. Aliment Pharmacol Ther 52:37–53

Article  PubMed  Google Scholar 

Gibson CM, Pass SE (2014) Enteral naloxone for the treatment of opioid-induced constipation in the medical intensive care unit. J Crit Care 29:803–807

Article  CAS  PubMed  Google Scholar 

Yuan C-S, Foss JF, O’Connor M et al (2000) Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA 283:367–372

Article  CAS  PubMed  Google Scholar 

Samokhvalov A, Sproule B, Selby P et al (2015) Oral naloxone for methadone-induced constipation: preliminary results of a randomized placebo-controlled trial. Eur Psychiatry 30:1–1

Article  Google Scholar 

Samokhvalov, AV Rehm J (2015), Opioid-induced constipation reversal in response to placebo in a patient with a history of IBS receiving methadone maintenance therapy. BMJ Case Rep 2015

Hatswell AJ, Vegter S (2016) Measuring quality of life in opioid-induced constipation: mapping EQ-5D-3 L and PAC-QOL. Health Econ Rev 6:14

Article  PubMed  PubMed Central  Google Scholar 

Stotts AL, Dodrill CL, Kosten TR (2009) Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother 10:1727–1740

Article  CAS  PubMed  PubMed Central  Google Scholar 

Slappendel R, Simpson K, Dubois D et al (2006) Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. Eur J Pain 10:209–217

Article  PubMed  Google Scholar 

Agachan F, Chen T, Pfeifer J et al (1996) A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 39:681–685

Article  CAS  PubMed  Google Scholar 

Yiannakou Y, Tack J, Piessevaux H et al (2017) The PAC-SYM questionnaire for chronic constipation: defining the minimal important difference. Aliment Pharmacol Ther 46:1103–1111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmedzai SH, Nauck F, Bar-Sela G et al (2012) A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliat Med 26:50–60

Article  PubMed  PubMed Central  Google Scholar 

Kurz A, Sessler DI (2003) Opioid-induced bowel dysfunction. Drugs 63:649–671

Article  CAS  PubMed  Google Scholar 

Bidary MZ, Sahranavard M, Rezayat AA et al (2021) Opium as a carcinogen: a systematic review and meta-analysis. E Clin Med 33

Google Scholar 

Sarbaz M, Kimiafar K, Khadem-Rezaiyan M et al (2019) Medical and surgical complications in three tertiary hospitals in the northeast of Iran: a multicenter study. Rev Clin Med 6:40–44

Google Scholar 

Noble M, Tregear SJ, Treadwell JR et al (2008) Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage 35:214–228

Article  PubMed  Google Scholar 

Culpepper-Morgan JA, Inturrisi CE, Portenoy RK et al (1992) Treatment of opioid-induced constipation with oral naloxone: a pilot study. Clin Pharmacol Ther 52:90–95

Article  CAS  PubMed  Google Scholar 

Vieweg WVR, Lipps WFC, Fernandez A (2005) Opioids and methadone equivalents for clinicians. Prim Care Companion J Clin Psychiatry 7:86

PubMed  PubMed Central  Google Scholar 

Olmo M, González-Barboteo J, Moreno-Alonso D et al (2021) Acute opioid withdrawal syndrome from naloxone/naloxegol interaction. BMJ Support Palliat Care 11:408–410

Article  PubMed  Google Scholar 

Meissner W, Schmidt U, Hartmann M et al (2000) Oral naloxone reverses opioid-associated constipation. Pain 84:105–109

Article  CAS  PubMed  Google Scholar 

Liu M, Wittbrodt E (2002) Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage 23:48–53

Article  PubMed  Google Scholar 

Trøstheim M, Eikemo M, Haaker J et al (2023) Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade. Neuropsychopharmacology 48:299–307

Article  PubMed  Google Scholar 

Moshiri M, Chaeideh B, Ebrahimi M et al (2024) Buprenorphine induced opioid withdrawal syndrome relieved by adjunctive magnesium: a clinical trial. J Subst Use Addict Treat 160:209307

Article  CAS  PubMed  Google Scholar 

Wong A, Macleod D, Robinson J et al (2015) Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally. Clin Toxicol (Phila) 53:815–818

Article  CAS  PubMed  Google Scholar 

Go S-I, Kim JH, Kang JH (2023) Treatment of opioid withdrawal syndrome triggered by oxycodone/naloxone with dexmedetomidine. J Hosp Palliat Care 26:18–21

PubMed  PubMed Central  Google Scholar 

Vahabzadeh M, Balali-Mood M, Banagozar Mohammadi A et al (2021) Efficacy and expenses of succimer vs. d-penicillamine plus garlic in the treatment of lead poisoning: a retrospective cross-sectional study. Daru 29:477–481

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dadpour B, Mehrpour O, Etemad L et al (2013) Lead poisoning-induced hypertensive crisis managed by prazosin: a case report. Iran Red Crescent Med J 15:526–528

Article  PubMed  PubMed Central  Google Scholar